Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal Failure

Summary

The purpose of this study is to determine if oral Heme Iron Polypeptide is as effective as intravenous (IV) iron sucrose in the treatment of iron-deficiency anemia for patients with chronic kidney disease.

Timeline

Start

2007-05

Primary completion

2011-12

Completion

2011-12

Outcome

Missed primary endpoint

paper After 6 months of treatment, Hb in the HIP group was 117 g/L and 113 g/L in the IV sucrose group (p = 0.37). PMID 23514036 ↗

Publications

• Nagaraju SP, Cohn A, Akbari A, Davis JL, Zimmerman DL. Heme iron polypeptide for the treatment of iron deficiency anemia in non-dialysis chronic kidney disease patients: a randomized controlled trial. BMC Nephrol. 2013 Mar 20;14:64. doi: 10.1186/1471-2369-14-64.

Drugs

Indications